Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Universitario La Paz (2)

2024

  1. Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer

    Clinical Drug Investigation, Vol. 44, Núm. 8, pp. 553-576

2021

  1. Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus

    Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1304-1313